Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
107.54
(
0.78%
)
Bitcoin
77,961.36
(
-0.24%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: iwfal post# 133757

Friday, 12/23/2011 6:14:42 PM

Friday, December 23, 2011 6:14:42 PM

Post# of 257580

Ok - agree that is good estimate. It is what I was using in general for branded biologics. Now the other assumption? (What would be a fair split of Gross Profit for mHumira)

That’s yesterday’s query, not today’s. Now that an FoB deal has actually been struck, what I need to ascertain is how much economic value MNTA will garner from the partnership. Whether BAX got the better of MNTA, MNTA got the better of BAX, or the deal was exactly fair in every respect is no longer of great consequence to me as a MNTA investor.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today